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Toll-like receptor 4 (TLR4) is a critical component of innate immune signaling andhas been implicated in alcohol responses inpreclinical
and clinical models. Members of the Integrative Neuroscience Initiative on Alcoholism (INIA-Neuroimmune) consortium tested the
hypothesis that TLR4mediates excessive ethanol drinking using the followingmodels: (1) Tlr4 knock-out (KO) rats, (2) selective knock-
down of Tlr4mRNA in mouse nucleus accumbens (NAc), and (3) injection of the TLR4 antagonist ()-naloxone in mice. Lipopolysac-
charide (LPS) decreased food/water intake and body weight in ethanol-naive and ethanol-trained wild-type (WT), but not Tlr4 KO rats.
There were no consistent genotypic differences in two-bottle choice chronic ethanol intake or operant self-administration in rats before
or after dependence. In mice, ()-naloxone did not decrease drinking-in-the-dark and only modestly inhibited dependence-driven
consumption at the highest dose. Tlr4 knockdown in mouse NAc did not decrease drinking in the two-bottle choice continuous or
intermittent access tests. However, the latency to ethanol-induced loss of righting reflex increased and the duration decreased in KO
versusWT rats. In rat central amygdala neurons, deletion ofTlr4 alteredGABAA receptor function, but not GABA release. Although there
were no genotype differences in acute ethanol effects before or after chronic intermittent ethanol exposure, genotype differences were
observed after LPS exposure. Using different species and sexes, different methods to inhibit TLR4 signaling, and different ethanol
consumption tests, our comprehensive studies indicate that TLR4 may play a role in ethanol-induced sedation and GABAA receptor
function, but does not regulate excessive drinking directly and would not be an effective therapeutic target.
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Introduction
Gene expression studies have shown strong representation of
immune- and inflammatory-related genes in brains from human
alcoholics and rodents after chronic alcohol treatment (Liu et al.,
2006; Robinson et al., 2014; Crews and Vetreno, 2016). Deletion
of immune genes reduced alcohol consumption inmice and pro-
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Significance Statement
Toll-like receptor 4 (TLR4) is a key mediator of innate immune signaling and has been implicated in alcohol responses in animal
models and human alcoholics. Members of the Integrative Neuroscience Initiative on Alcoholism (INIA-Neuroimmune) consor-
tium participated in the first comprehensive study across multiple laboratories to test the hypothesis that TLR4 regulates exces-
sive alcohol consumption in different species and different models of chronic, dependence-driven, and binge-like drinking.
Although TLR4 was not a critical determinant of excessive drinking, it was important in the acute sedative effects of alcohol.
Current research efforts are directed at determiningwhich neuroimmune pathwaysmediate excessive alcohol drinking and these
findings will help to prioritize relevant pathways and potential therapeutic targets.
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vided corroborating behavioral validation for several immune
mediators that were predicted by the genomic studies (Blednov et
al., 2012; Mayfield et al., 2013). In addition, alcohol craving and
consumptionwere positively correlatedwith elevated plasma lev-
els of inflammatory cytokines in human alcoholics (Leclercq et
al., 2012; Leclercq et al., 2014) and immunemarker expression in
human postmortem brain was correlated with total lifetime alco-
hol consumption and age of drinking onset (Crews and Vetreno,
2016).
Current research efforts are focused on determining which neu-
roimmune/inflammatory pathways are important formediating ex-
cessive alcohol drinking. The family of Toll-like receptors (TLRs), in
particular TLR4, is a major component of innate immune signaling
and has been hypothesized tomediate inflammatory effects of alco-
hol in the brain (Alfonso-Loeches et al., 2010; Szabo and Lippai,
2014; Alfonso-Loeches et al., 2016). TLR4 activation is triggered
through pathogen-derived ligands, such as the bacterial endotoxin
lipopolysaccharide (LPS) and endogenous ligands including high
mobility group box 1 protein (Vezzani et al., 2011). Acute ethanol
exposure activates TLR4 signaling in brain astrocytes andmicroglia
(Blanco et al., 2005; Fernandez-Lizarbe et al., 2013) and chronic
ethanol also triggers TLR4-mediated neuroimmune responses (Lip-
pai et al., 2013; Pascual et al., 2015; Alfonso-Loeches et al., 2016).
Some studies have suggested a role for TLR4 in ethanol drink-
ing, although this has not been observed consistently. Systemic
injection of LPS (a primary TLR4 ligand) increased voluntary
ethanol consumption in mice (Blednov et al., 2011) and elevated
plasma levels of LPS, alongwith increased intestinal permeability,
were measured in human alcoholics (Leclercq et al., 2012). Selec-
tive knockdown of TLR4 in the CeA or the ventral tegmental area
(VTA) (but not the ventral pallidum, VP) decreased binge drink-
ing in alcohol-preferring (P) rats (Liu et al., 2011; June et al.,
2015). Although TLR4 deficiency protected against ethanol-
induced glial activation and induction of inflammatory media-
tors, Tlr4 knock-out (KO) mice did not differ from wild-type
(WT)mice in chronic ethanol consumption (Alfonso-Loeches et
al., 2010; Pascual et al., 2011). The TLR4 antagonist T5342126
decreased drinking and the density of a microglial protein in the
CeA in ethanol-dependent and nondependent mice, but the de-
creased drinking was apparently due to nonspecific effects (Bajo
et al., 2016). Overall, there is strong evidence for activation of
TLR4 and other neuroimmune mediators in chronic ethanol ex-
posure, but a direct causal link between TLR4 and alcohol drink-
ing behavior has not been shown.
Members of the Integrative Neuroscience Initiative on Alco-
holism (INIA-Neuroimmune) consortium (http://www.inia-
west.org/) participated in extensive multidisciplinary studies
to test the hypothesis that TLR4 is directly involved in ethanol
drinking and other ethanol-related responses. TLR4 signaling
was inhibited using the following: (1) nullmutant rats lacking the
Tlr4 gene, (2) selective knockdown of Tlr4mRNA in the nucleus
accumbens (NAc) of mice using Cre recombinase-mediated Tlr4
gene excision, and (3) injection of the selective TLR4 antagonist
()-naloxone in C57BL/6J mice. None of these approaches pro-
vided consistent evidence that TLR4 regulates ethanol intake in
any drinking test in mice or rats. However, there was evidence
that TLR4 mediates the acute sedative effects of ethanol. Electro-
physiological studies revealed that genetic deletion ofTlr4did not
alter spontaneous GABA release in rat CeA neurons, but altered
the kinetics of GABAA receptor-mediated IPSCs.
Materials andMethods
Animals
Rats. A rat line on a Wistar background harboring a nonfunctional Tlr4
gene was produced using transcription activator-like effector nuclease
mediated mutagenesis as described previously (Ferguson et al., 2013).
This line carries a 13-base pair frame shift mutation in Tlr4 Exon 1 and
has a dramatically attenuated response to LPS challenge (Ferguson et al.,
2013). Heterozygous breeding pairs were produced at the University of
Pittsburgh (Pittsburgh, PA) and shipped to The Scripps Research Insti-
tute (La Jolla, CA) and the Indiana University School of Medicine (Indi-
anapolis). WT control and homozygous KO (Tlr4/) littermates
produced from these heterozygous pairs were used at the respective in-
stitutions. Offspring were weaned at 21 d of age and genotyped as
described previously (Ferguson et al., 2013).
Mice. Male 12-week-old C57BL/6J mice (The Jackson Laboratory)
were used to investigate the effects of ()-naloxone on ethanol drinking.
Mice were housed in groups of four before the drinking tests. Lights were
on a reverse 12 h light/12 h dark cycle (lights on at 8:00 P.M.). These
studies were conducted at The Scripps Research Institute.
Adultmalemice with a floxedTlr4 gene (i.e., mice withTlr4 flanked by
LoxP sites, denoted asTlr4F/F) were generated on aC57BL/6 background
as described previously (Sodhi et al., 2012) and used for knockdown
studies in the NAc. Original breeders were produced at the University of
Pittsburgh and mating pairs were shipped to The University of Texas at
Austin. Mice were group-housed 4–5 to a cage on a 12 h light/12 h dark
cycle (lights on at 7:00 A.M.). Ethanol consumption tests beganwhen the
mice were at least 2 months old.
Rats and mice at the different institutions were housed in temperature-
and humidity-controlled vivaria with water and food provided ad libitum.
All vivaria are approvedby theAssociation forAssessmentandAccreditation
of Laboratory Animal Care. All procedures adhered to the National Insti-
tutes of Health’sGuide for the Care and Use of Laboratory Animals and were
approved by the institutional animal care and use committees at each site.
LPS injections
Ethanol-naive adult male Tlr4 KO and WT rats (n  4 per genotype)
weighing 479–604 g at the beginning of the experiment were housed
individually on a 12 h light/12 h dark cycle (lights on at 6:00 A.M.).
Baseline body weight and food and water consumption were measured
24 h before LPS injection. Rats were injected intraperitoneally with 1
mg/kg LPS (L3024, Escherichia coli 0111:B4; Sigma-Aldrich) dissolved in
saline 30 min before the start of the dark cycle. Immediately before in-
jection and subsequently every 12 h for 7 d, body weight and food and
water intake were measured. Seven to 10 d after a single LPS injection, in
vitro electrophysiological experiments were performed to assess the acute
ethanol effects on CeA GABAergic transmission.
For LPS effects on operant ethanol self-administration, adult male
Tlr4 KO and WT rats (n  5 per genotype) weighing 350–375 g at the
beginning of the experiment were housed in groups of two per cage in a
temperature-controlled (22°C) vivarium on a 12 h light/12 h reversed
dark-light cycle (lights on at 10:00 P.M.). After completing operant eth-
anol self-administration training (described below), the rats were housed
individually, injected with LPS (1 mg/kg, i.p.), and body weight and
food/water intake were recorded daily. Ethanol and water self-
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administration testing were performed in 30 min sessions for 14 consec-
utive days followed by a secondLPS injection and 14more days of testing.
Baseline body weight and food and water consumption were measured
24 h before the first LPS injection.
LPS data are presented as themean SEM intake in 24 h (food, water)
or the percentage change relative to preinjection baseline (body weight).
Raw data (intake or body weight change, in grams, over a 24 h period)
were analyzed using two-way repeated-measures ANOVA with group
(Tlr4 KO vs WT) as the between-subjects factor and days since LPS
injection as the within-subjects factor. Bonferroni and Newman–Keuls
tests were used for post hoc analyses.
Ethanol intake tests in rats
Two-bottle choice (2BC). Rats were double-housed by sex and genotype
(Tlr4 KO vs WT). Lights were on a reverse 12 h light/12 h dark cycle
(lights on at 10:30 P.M.). On postnatal day 85, male and female rats were
transferred from their home cages and singly housed in hanging stainless
steel wire-mesh cages for habituation to this environment. Male and
female littermate offspring of each genotype were tested using the 2BC
ethanol consumption test beginning on postnatal day 90. Rats were given
ad libitum choice access to 10% ethanol (v/v) and water for 5 weeks.
Ethanol (grams per kilogram body weight) and water (milliliters per
kilogram body weight) consumption were assessed 5 d/week and body
weight (kilograms) was measured 3 d/week. Ethanol intake was con-
verted to grams of absolute (i.e., corrected for specific gravity) ethanol
consumed/kilogram of body weight/day. Due to daily fluctuations in
ethanol consumption in all groups, the data for each day were averaged
across each week of access. The weekly data were submitted to a 3 2
5 (genotype by sex by week) mixed-model ANOVA, with genotype and
sex as the between-subjects factors and week as the within-subjects
factor.
Operant self-administration. Adult male Tlr4 KO (n  12) and WT
(n  13) rats weighing 250–350 g at the beginning of the experiment
were housed in groups of two per cage in a temperature-controlled
(22°C) room on a reverse 12 h light/12 h dark cycle and the behavioral
tests were conducted during the dark phase of the circadian cycle.
Self-administration sessions were conducted in standard operant condi-
tioning chambers (Med Associates). Animals were first trained to self-
administer 10% ethanol (w/v) and water solutions until stable responses
were maintained. The rats were subjected to an overnight session in the
operant chambers with access to 1 lever (right lever) that delivered water
[fixed ratio 1 (FR1) schedule of reinforcement, i.e., each operant re-
sponse was reinforced with 0.1ml of the solution]. Food was available ad
libitum during training. After 1 d off, the rats were subjected to a 2 h
session (FR1) for 1 d and a 1 h session (FR1) the next day, with 1 lever
delivering ethanol (right lever). All of the subsequent sessions lasted 30
min and 2 levers were available (left lever: water; right lever: ethanol)
until stable levels of intake were reached. Upon completion of this pro-
cedure, the animals were allowed to self-administer 10% (w/v) ethanol
andwater (FR1). Self-administrationwas analyzed by two-way repeated-
measures ANOVAwith group as the between-subjects factor and session
as the within-subjects factor.
Chronic intermittent ethanol (CIE). Rats were made dependent by
chronic, intermittent exposure to ethanol vapor for 5–7 weeks as de-
scribed previously (O’Dell et al., 2004; Gilpin et al., 2008). They under-
went cycles of 14 h on [blood ethanol concentrations (BECs) during
vapor exposure ranged between 150 and 250 mg%] and 10 h off, during
which behavioral testing for acute withdrawal and operant self-
administration (see below) occurred (i.e., 6–8 h after vapor was turned
off when brain andBECs are negligible; Gilpin et al., 2009). In thismodel,
rats exhibit somatic withdrawal signs and negative emotional symptoms
reflected by anxiety-like responses and elevated brain reward thresholds
(Schulteis et al., 1995; Roberts et al., 2000; Valdez et al., 2002; Rimondini
et al., 2003; O’Dell et al., 2004; Sommer et al., 2007; Zhao et al., 2007;
Edwards et al., 2012; Vendruscolo and Roberts, 2014). For the electro-
physiology experiments, the rats were kept in the vapor chambers until
they were killed.
Operant self-administration during CIE vapor exposure. Behavioral
testing occurred three times per week. The rats were tested for 10%
ethanol (andwater) self-administration on an FR1 schedule of reinforce-
ment in 30min sessions.Operant self-administration on anFR1 schedule
requires minimal effort by the animal to obtain the reinforcement and
herein was considered a measure of intake. Ethanol self-administration
data were analyzed by two-way repeated-measures ANOVA with group
(Tlr4KOvsWT) as the between-subjects factor and session as thewithin-
subjects factor. Because the same rats were used to measure predepen-
dent versus dependent ethanol self-administration, the number of
lever presses for ethanol (last six sessions before ethanol vapor expo-
sure) were averaged and compared with the average lever presses
across six self-administration sessions during ethanol vapor expo-
sure. Data were analyzed using two-way mixed models ANOVA with
group as the between-subjects factor and time (predependent vs de-
pendent) as the within-subjects factor.
Ethanol intake tests in mice
Drinking-in-the-dark (DID). The DID procedure is a binge-like drinking
model, which capitalizes on the circadian rhythm in drinking and uses a
discrete time of exposure to ethanol to optimize pharmacologically sig-
nificant ethanol drinking (Rhodes et al., 2005; Rhodes et al., 2007; Thiele
et al., 2014). Three factors are important in this model: (1) providing
access to ethanol a few hours into the dark cycle, (2) not allowing access
to water when ethanol is offered, and (3) using genetically predisposed
mice. BECs in C57BL/6J mice in this model are reliably100 mg% after
the final drinking period and motor impairments are detected using the
accelerating rotarod and balance beam tests (Rhodes et al., 2005, 2007).
C57BL/6Jmice were individually housed 1week before testing. On day 1,
starting 3 h after lights off (11:00 A.M.), water bottles were replaced with
drinking tubes containing 20% ethanol in tap water for 2 h. On day 4, the
ethanol bottles remained for 4 h, with intakes recorded after both 2 and
4 h. Immediately after removal of the ethanol bottles, tail blood was
sampled to measure BEC. On day 4, mice were injected with ()-
naloxone (0, 30, or 60 mg/kg; n 8 per group) 30 min before the drink-
ing session began (10:30 A.M.) to investigate its acute effects. The
following week, saline or 60 mg/kg ()-naloxone (n 8 per group) was
injected on all 4 d of DID testing 30 min before the drinking sessions to
examine subchronic effects. ()-Naloxone was synthesized by E.R. and
freshly dissolved in saline and administered intraperitoneally at 0.01ml/g
body weight. The -opioid inactive stereoisomer, ()-naloxone, is a
selective TLR4 inhibitor (Hutchinson et al., 2008; Wang et al., 2016).
Data were analyzed separately at the 2 and 4 h time points using one-way
ANOVA with ()-naloxone dose as the between-subjects factor.
CIE-2BC. In the CIE-2BC model, excessive ethanol consumption is
observed after 2BC limited-access periods are cycledwith chronic passive
exposure to ethanol vapor in rats (Vendruscolo and Roberts, 2014) or
C57BL/6J mice (Becker and Lopez, 2004; Finn et al., 2007; Griffin et al.,
2009). This has been used to model the motivational aspects of alcohol
dependence and the excessive drinking associatedwith the addicted state.
For 15 d (5 d per week for 3 weeks), 30 min before the lights turn off
(7:30 A.M.), C57BL/6J mice were individually housed for 2 h with access
to 2 drinking tubes containing either 15% ethanol or water. Ethanol and
water consumption during these 2 h periods were recorded. After this
baseline period, mice were divided, based on equal ethanol and water
consumptions, into two balanced groups to be exposed to CIE or air in
identical vapor chambers. After baseline 2BC drinking, the CIE group
was injected with 1.75 g/kg ethanol plus 68 mg/kg pyrazole (alcohol
dehydrogenase inhibitor) and placed in the chambers to receive inter-
mittent vapor for 4 d (vapor on for 16 h and off for 8 h). After each 16 h
period of vapor, mice were removed and, on the second and fourth days,
tail blood was sampled to determine BEC. Target BECs were 175–250
mg%. After the fourth day of exposure, mice were allowed 72 h of undis-
turbed time and were then given 5 d of 2 h access to bottles containing
15% ethanol and water tomeasure ethanol drinking and preference after
vapor exposure. The control group was injected with 68 mg/kg pyrazole
in saline and placed in chambers delivering air for the same periods as the
CIE group and received 2BC testing at the same time as the ethanol vapor
group. The vapor/air exposure and 5 d of 2BC testing were repeated for a
total of 4 rounds of vapor and 2BC testing before ()-naloxone testing.
For the first study, 30 mice (n 15 per group) were administered ()-
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naloxone (0, 3, 10, 30, 60 mg/kg) in a within-subjects manner 30 min
before 2BC testing (7:00 A.M.). Drug injections were given every 3–4 d.
For the second study, 20micewere used in a between-subject design (n
4–6 in 4 groups: control-vehicle, control-60 mg/kg ()-naloxone, CIE-
vehicle, CIE-60 mg/kg ()-naloxone). Mice were injected 30min before
the 2BC procedure across 4 d of testing. Data from the first study were
analyzed by two-way repeated-measures ANOVA (group as the between
factor; dose as the within factor) and data from the second study were
analyzed by three-way repeated-measures ANOVA (group and dose as
the between factors; day as the within factor). Significant effects were
further investigated using Fisher’s protected (P)LSD tests.
2BC (24 h continuous access). Four weeks after lentiviral Cre-
recombinase injections in the NAc to knock down Tlr4 selectively (see
below), a 2BC protocol was performed as described previously (Blednov
et al., 2003). Tlr4F/F male mice were allowed to acclimate for 1 week to
individual housing. Two drinking bottles (containingwater and ethanol)
were available continuously to each mouse and bottles were weighed
daily. Bottle positions were changed daily to control for position prefer-
ences.Micewereweighed every 4 d. After 4 d ofwater consumption (both
bottles contained water), mice were offered 3% ethanol (v/v) versus
water for 4 d. The amount of ethanol consumed (g/kg body weight per
24 h) was calculated for each mouse and these values were averaged for
every concentration of ethanol. Immediately after 3% ethanol, a choice
between 6% ethanol and water was offered for 2 d, followed by 8%, 10%,
12%, 14%, and finally 16% (v/v) ethanol (each concentrationwas offered
for 4 d). Throughout the experiment, evaporation/spillage estimates
were calculated daily using two bottles (containing water or the appro-
priate ethanol solution) placed in an empty cage. Data were analyzed by
two-way repeated-measures ANOVA followed by Bonferroni post hoc
tests.
2BC (24 h intermittent access). Intermittent (every other day) access to
ethanol increases voluntary ethanol consumption in mice (Melendez,
2011). This drinking paradigm was tested in a different group of Tlr4F/F
male mice 4 weeks after lentivirus injections in the NAc.Mice were given
access to a bottle of 15% (v/v) ethanol and a bottle of water during 24 h
sessions every other day. The placement of the ethanol bottles was alter-
nated with each drinking session to control for side preferences. The
quantity of ethanol consumedwas calculated as grams per kilogrambody
weight per 24 h. Evaporation/spillage estimates were calculated daily
from two bottles (containingwater or 15% ethanol solution) placed in an
empty cage. Data were analyzed by two-way repeated-measures ANOVA
followed by Bonferroni post hoc tests.
Acute behavioral effects
Ethanol-induced loss of righting reflex (LORR). Adult male Tlr4 KO and
WT rats (n  10 per genotype) weighing 350–400 g were housed in
groups of two per cage. Each rat was handled 5 min/d for 1 week before
beginning the experiment. On test day, the rats were injected with 4 g/kg
ethanol (20% v/v in saline, i.p.). After injection, the rat was placed in a
supine position on a V-shaped platform. The time to LORR (time be-
tween the injection and the moment in which the rat is not able to right
himself) and the time of LORR (interval between the loss of ability to flip
over onto all four limbs when placed in a supine position and the time
when this reflex was successfully demonstrated three consecutive times
within 60 s) were scored. Data were analyzed using an unpaired t test.
Selective knockdown of TLR4 in mouse NAc
Lentivirus-mediated knockdown of Tlr4. Tlr4F/F male mice received bilat-
eral injections into the NAc with either a vesicular stomatitis virus
(VSV-G) pseudotyped lentivirus expressing Cre recombinase fused to an
enhanced green fluorescent protein (EGFP) under the control of a cyto-
megalovirus (CMV) promoter (LV-Cre-EGFP) or an “empty” VSV-G
pseudotyped lentivirus vector expressing only the EGFP transgene under
a CMV promoter (LV-EGFP-Empty). Virus was produced as described
previously (Lasek et al., 2007). Mice were anesthetized by isoflurane in-
halation, placed in a model 1900 stereotaxic apparatus (Kopf Instru-
ments), and administered preoperative analgesic (Rimadyl, 5 mg/kg).
The skull was exposed and bregma and lambda visualized with a dissect-
ing microscope. A digitizer attached to the micromanipulator of the
stereotaxic apparatus was used to locate coordinates relative to bregma.
Burr holes were drilled bilaterally above the injection sites in the skull
using a drill equipped with a #75 carbide bit (Kopf Instruments). The
injection sites targeted the NAc using the following coordinates relative
to bregma: anteroposterior (AP) 1.49 mm, mediolateral (ML) 0.9
mm, and dorsoventral (DV)4.8 mm. Injections were performed using
aHamilton 10l microsyringe (model 1701) and a 30-gauge needle. The
needle tip was lowered to the DV coordinate and retracted 0.2 mm. The
Figure1. Tlr4KO rats are resistant to LPS-induced toxicity. LPS produced transient reduction
of food (A) and water (B) intake in male WT but not Tlr4 KO rats. The data are presented as
mean SEM food and water intake (in grams) in 24 h periods. Day 0 represents intake mea-
sured during the 24 h before LPS (1mg/kg, i.p.) injection. C, LPS induced a robustweight loss in
WT but not Tlr4 KO rats. The data are presented as percentage change relative to preinjection
baseline weight (error bars are obscured by the symbols). Data were analyzed by two-way
repeated-measures ANOVA followed by Bonferroni post hoc tests; *p	 0.05, **p	 0.01,
***p	 0.001 compared with baseline; n 4 per genotype. Arrows indicate injection of LPS
(1 mg/kg, i.p.).
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viral solution (1.0 l with titer of 3  107 pg gag antigen/ml in PBS,
PBS) was injected into each site at a rate of 200 nl per min. After each
injection, the syringe was left in place for 5 min before being retracted
over a period of 3 min. Incisions were closed with tissue adhesive (Vet-
bond; 3M). Mice were housed individually after surgery and given a
4-week recovery period before starting the ethanol drinking tests. Sepa-
rate groups of mice were used for each 2BC test.
RNA isolation. Approximately half of the treated Tlr4F/F mice were
killed within 24 h of completing the drinking tests. The brains were
quickly removed, flash frozen in liquid nitrogen, and later frozen in
optimal cutting temperature medium (VWR) in isopentane on dry ice
and stored at80°C. Brains were transferred to a cryostat set at6°C for
at least 1 h before sectioning. Sections (300 m) were collected from
1.80 to 0.60 mm (AP) relative to bregma and transferred to glass
slides that had been precooled on dry ice. Mi-
cropunch sampling was performed on a frozen
stage (25°C) using a dual fluorescent protein
flashlight (Nightsea) and the stereotaxic atlas
of Paxinos and Franklin (2004) to confirm
EGFP expression and the anatomical location
of the injection site, respectively. Microdissec-
tion punches (Stoelting) with an inner diame-
ter of 0.75 mm were used to obtain samples of
NAc core and shell. This inner diameter corre-
sponded to the viral spread around the injec-
tion site and minimized contamination from
other tissue. Punches were taken bilaterally
from four 300 m sections and stored at
80°C until RNA extraction. All equipment
and surfaces involved in the collection of tissue
were treated with 100% ethanol and RNaseZap
(LifeTechnologies) topreventRNAdegradation.
Total RNAwas extracted using theMagMAX-96
for Microarrays Total RNA Isolation Kit (Life
Technologies) according to the manufacturer’s
instructions. Yields and purity were assessed us-
ingaNanoDrop8000(ThermoFisherScientific),
and quality of the total RNA preparation was de-
termined using the Agilent 2200 TapeStation.
Quantitative real-time PCR. To verify Tlr4
mRNA knockdown, single-stranded cDNA was
synthesized from total RNA using the TaqMan
High Capacity RNA-to-cDNA kit (Life Technol-
ogies). After reverse transcription, quantitative
real-time PCR (qPCR) was performed in tripli-
cate using TaqMan Gene Expression Assays to-
getherwith theTaqManGeneExpressionMaster
Mix (Life Technologies) per the manufacturer’s
instructions. The TaqMan Gene Expression as-
says used were Tlr4 (Mm00445273_m1) and en-
hanced GFP (Mr04097229_mr). Gapdh
(Mm99999915_g1) was used as a reference gene
and relativemRNA levels were determined using
the 2

CT method (Schmittgen and Livak,
2008). Gapdh was used as the endogenous con-
trol because of its stable expression across sam-
ples. Reactions were performed in a CFX384
Real-TimePCRDetection System (Bio-Rad) and
data collected using Bio-Rad CFXManager.
Target site verification. The other half of the
Tlr4F/F-treated mice were killed within 24 h of
completing the drinking tests and transcardially
perfusedwith PBS, pH 7.4, followed by 4%para-
formaldehyde (PFA). Brains were harvested,
postfixed for24h in4%PFAat4°C, andcryopro-
tected for 24 h in 20% sucrose in PBS at 4°C.
Brains were placed in molds containing optimal
cutting temperature compound (VWR) and fro-
zen in isopentane on dry ice. The brains were
equilibrated in a 12 to 14°C cryostat
(Thermo Fisher Scientific) for at least 1 h and coronal 40msections of the
NAcwere placed in sterile PBS. Serial sections (40m)ofNAc (AP2.00 to
0.00 mm) were mounted on slides with DAPI mounting medium (Vector
Laboratories) and visualized using a Zeiss Axiovert 200M Fluorescent Mi-
croscopeequippedwitha10objective toassess the locationof the injection
site. Quality of injection was scored quantitatively based on the strength of
EGFP viral expression, injection location relative to target, and the spread of
the virus. The injection was considered on target if the virus covered at least
one-third of the NAc.
Whole-cell voltage-clamp electrophysiology
Slice preparation.MaleWT andTlr4KO rats (used previously for operant
self-administration testing) were made ethanol dependent by CIE vapor
Figure 2. Tlr4 KO rats trained to self-administer ethanol (10%) are resistant to LPS-induced toxicity. The data are presented as
mean SEM of food (A) andwater (B) intake in 24 h inmaleWT (n 5) and Tlr4 KO (n 5) rats. Day 0 corresponds to intake for
the 24 h before LPS (1 mg/kg, i.p.) injection. C, Time course of the change in body weight over 24 h in male rats. The data are
presented as the percentage change relative to the preinjection baseline weight measured before the first LPS injection. D, Time
course of the change in body weight of LPS-treatedWT and KO rats after the first and second LPS injections. LPS-induced changes
inbodyweight are expressedas thepercentage change relative to themost recent preinjectionweight. InWT rats, paired Student’s
t test (t(4) 6.0, p	 0.01) showed a significant decrease in loss of body weight 1–4 d after the second LPS injection (3.4
0.5%) compared with the weight loss after the first LPS injection (7.1 0.7%). There was no significant difference in the LPS
effects between the first and second LPS injections in the Tlr4 KO rats. Arrows indicate injection of LPS (1 mg/kg, i.p.).
Figure 3. LPS induces transient reduction in ethanol (10%) self-administration in WT but not Tlr4 KO rats. Effect of LPS
injections on ethanol (A) and water (B) self-administration in male WT and Tlr4 KO rats. The data are presented as mean SEM
lever presses during 30 min sessions. Baseline (BL) was calculated as the average of the last 4 sessions before each LPS injection.
Rats were given two LPS (1 mg/kg, i.p.) injections 14 d apart and the data from both injections were averaged. The average lever
presses1–4dand5–12dafter LPSare shown.Datawereanalyzedbymixed-factorial ANOVA followedbyNewman–Keulspost hoc
test; *p	 0.05 compared with KO; n 5 per genotype.
Harris et al. • TLR4 and Alcohol Responses J. Neurosci., February 1, 2017 • 37(5):1139–1155 • 1143
exposure as described earlier and kept in the vapor chambers until time
for electrophysiological studies. BECs were measured once or twice per
week by tail bleeding and again before euthanasia. The mean BEC of all
ethanol-exposed animals was 173.0  21 mg/dl. Slices were prepared
from 14 naive control, CIE WT, and Tlr4 KO rats (425–595 g) as de-
scribed previously (Gilpin et al., 2011; Cruz et al., 2012). Briefly, rats were
anesthetized using 3–5% isoflurane, rapidly decapitated, and the brains
placed in ice-cold high-sucrose solution, pH 7.3–7.4, containing the fol-
lowing (in mM): sucrose (206), KCl (2.5), CaCl2 (0.5), MgCl2 (7),
NaH2PO4 (1.2), NaHCO3 (26), glucose (5), and HEPES (5). Coronal
brain slices (300 m) were cut on a vibrating microtome (Leica
VT1000S) and transferred to an oxygenated (95% O2/5% CO2) artificial
CSF (aCSF) solution containing the following (in mM): NaCl (130), KCl
(3.5), CaCl2 (2), NaH2PO4 (1.25), MgSO4 (1.5), NaHCO3 (24), and glu-
cose (10). Slices were incubated (30min; 35–37°C) and then equilibrated
at room temperature for 30min. For each recording, a slice was placed in
a recording chamber mounted on the stage of an upright microscope
(Olympus BX50WI) and perfused (2–5 ml/min) with continuously oxy-
genated aCSF at room temperature.
Electrophysiological recording. Medial subdivision CeA neurons
(n 84) were visualized using infrared differential interference contrast
(IR-DIC) optics, a CCDcamera (EXiAqua andROLERA-XR;QImaging;
Gilpin et al., 2011; Cruz et al., 2012) and a w60 or w40 water-immersion
objective (Olympus Scientific Solutions). Recordings were performed in
a gap-free acquisitionmodewith a sampling rate per signal of 10 kHz and
low-pass filtered at 10 kHz using a Multiclamp 700B amplifier and Digi-
data 1440A and pClamp 10 software (Molecular Devices). Borosilicate
glass patch pipettes (3–6 M) (Warner Instruments) were filled with an
internal solution containing the following (in mM): KCl (145), EGTA (5),
MgCl2 (5), HEPES (10), Na-ATP (2), and Na-GTP (0.2). Spontaneous IP-
SCs (sIPSCs) mediated by GABAA receptors were isolated by adding gluta-
mate receptor blockers 6,7-dinitroquinoxaline-2,3-dione (DNQX, 20 M;
Tocris Bioscience) and DL-2-amino-5-phosphonovalerate (AP-5, 30 M;
Tocris Bioscience) and the GABAB receptor antagonist CGP55845A
(1M; Sigma-Aldrich) directly to the aCSF.GABAergicminiature IPSCs (mIP-
SCs)wereisolatedusingglutamatergicandGABABreceptorblockersand0.5M
tetrodotoxin (Biotum).All drugswere applied by bath superfusion.
Cells were clamped at60 mV and recordings showing a series resis-
tance15M or a20% change in series resistance, as monitored with
a 10mVpulse, were excluded. s/mIPSC frequency, amplitude, and kinet-
ics were analyzed using semiautomated threshold-based mini detection
software (Mini Analysis; Synaptosoft) and inspected visually. Only
s/mIPSCs with amplitude 5 pA were accepted for analysis and final
averages of s/mIPSC characteristics were derived from a minimum time
interval of 2–5 min. GraphPad Prism 5.0 software was used for all statis-
tical analyses. The s/mIPSC data were evaluated with cumulative proba-
bility analysis and statistical significance was determined using the
Kolmogorov–Smirnov nonparametric two-sample test (Van der Kloot,
1991), with p	 0.05 considered significant. To assess whether differences
in ethanol’s effects on s/mIPSCs result from the treatment (naive, ethanol-
dependent, andLPS-injected) and/or genotype (WTandTlr4KOrats), two-
way ANOVAs of the normalized values were performed (mean values of
s/mIPSC characteristics during ethanol application divided by the baseline
values). When appropriate, Bonferroni post hoc tests were used to assess
significance between treatments. All data are presented asmean SEMand
n refers to the number of neurons. One to five neurons were recorded per
animal and all electrophysiological measures were obtained by pooling data
from at least three animals per experimental group.
Results
Lack of LPS effects in Tlr4KO rats
Tlr4 KO ethanol-naive rats are resistant to LPS-induced toxicity
Wemonitored reductions in food intake (anorexia), water intake
(adipsia), and body weight as signs of LPS-induced “sickness-
like” behavior (McCarthy et al., 1984; Cross-Mellor et al., 2000;
van Heesch et al., 2013) in naive and ethanol self-administering
Tlr4 KO and WT rats. Baseline measures of body weight or food
and water consumption did not differ in KO and WT rats. In
naive rats, LPS (1 mg/kg, i.p.) caused a transient reduction of
food intake in WT, but not Tlr4 KO rats (Fig. 1A). There were
significant main effects of LPS (F(7,42)  60.7, p 	 0.0001) and
genotype (F(1,42) 13.7, p	 0.01) on food intake and an inter-
action between the factors (F(7,42) 30.2, p	 0.001). Profound
anorexia occurred within 24 h after injection in WT rats, which
persisted for at least 48 h (28.1 2.0 g consumed 24 h before LPS
vs 1.2 0.8 g after LPS). WT rats gradually increased their food
intake, reaching pre-LPS consumption levels by the sixth postin-
jection day (25.8 3.4 g). In Tlr4KO rats, LPS caused a transient
reduction in food intake (from 27.6 3.7 g to 22.9 3.2 g) after
24 h, followed by increased food intake on the fourth postinjec-
tion day (34.2 1.5 g).
Figure 4. There was no effect of genotype on ethanol self-administration in WT or Tlr4 KO
rats before or after dependence. A, Male WT and Tlr4 KO rats do not differ in ethanol (10%)
self-administration before ethanol vapor exposure. The data are presented as mean SEM
lever presses during 30 min sessions. Data were analyzed by two-way repeated-measures
ANOVA with group as the between-subjects factor and session as the within-subjects factor.
B, Male WT and Tlr4 KO rats do not differ in ethanol (10%) self-administration after CIE expo-
sure. Ethanol-dependent rats underwent cycles of 14hon (BEC: 146.83.6mg%)and10hoff.
The same rats were used to measure predependent versus postdependent ethanol self-
administration. For baseline, the number of lever presses for ethanol (last six sessions before
ethanol vapor exposure)was averaged and comparedwith the average number of lever presses
over six self-administration sessions during CIE exposure. The data are presented as mean
SEM lever presses during 30 min sessions. Data were analyzed using two-way ANOVA with
group as the between-subjects factor and time (predependent vs dependent) as the within-
subjects factor (n 8 for WT and n 7 for KO, *p	 0.05 compared with baseline).
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LPS reduced water intake inWT rats only (Fig. 1B); this effect
peaked on the second postinjection day, with drinking levels re-
turning to baseline by the fourth postinjection day. There were
main effects of LPS on water intake (F(7,42) 7.1, p	 0.001) and
a significant interaction between LPS and genotype (F(7,42) 4.8,
p	 0.001), but the main effect of genotype did not reach signif-
icance (p  0.05). Reductions in food and water intake in WT
rats were accompanied by significant weight loss, a pattern not
observed in KO rats. LPS produced weight loss inWT rats during
the first 3 postinjection days, reaching a peak loss of 10% body
weight (Fig. 1C) (main effects of LPS (F(7,42) 88.2, p	 0.001)
and genotype (F(7,42)  79.6, p 	 0.001) and an interaction be-
tween the factors (F(7,42)  73.6, p 	 0.001). Body weight then
stabilized and the resumption of food intake was associated with
the reappearance of normal diurnal fluctuations in body weight
when measured every 12 h, similar to Tlr4 KO rats (data not
shown). Although a slight reduction in body weight was also
observed in the 24–48 h after LPS injection in Tlr4 KO rats, its
magnitude was	25% of that observed in WT (2.5% absolute
weight loss). The resistance of Tlr4 KO rats to LPS-induced
“sickness-like behavior” provides behavioral and functional val-
idation that the Tlr4 gene had been deleted.
Tlr4 KO rats trained to self-administer ethanol are resistant to
LPS-induced toxicity
Similar to naive rats, there were no significant differences in base-
line body weight or water and food intake in theWT andTlr4KO
rats trained to self-administer 10% ethanol. LPS injections (14 d
apart) significantly (p 	 0.001) reduced food intake in WT but
not KO ethanol-trained rats (Fig. 2A). Two-way repeated-mea-
suresANOVAshowedmain effects of LPS (F(4,32) 63.9, p	 0.001)
and genotype (F(1,32) 8.4, p	 0.05) on food intake, as well as an
interaction between the factors (F(4,32)  43.8, p 	 0.001). Al-
though water intake was reduced after
both LPS injections inWT rats, the intake
over the 4 d period after LPS was reduced
significantly only after the first injection
(Fig. 2B), suggesting the development of
tolerance to its effects. There were no ef-
fects of LPS injections on water intake in
Tlr4 KO rats. There were main effects of
LPS on water consumption (F(4,32) 5.1,
p 	 0.001) and an interaction between
LPS and genotype (F(4,32)  4.0, p 	
0.001) without a main effect of genotype.
In WT rats, two LPS injections in-
duced a significant loss in body weight
measured over a 4 d period after each
injection (Fig. 2C). Two-way repeated-
measures ANOVA showed main effects
of LPS (F(4,32)  35.8, p 	 0.001) and
genotype (F(1,32) 68.4, p	 0.001) and
an interaction between the factors
(F(4,36)  17.1, p 	 0.001). LPS injec-
tions had no effect on the body weight of
Tlr4 KO rats (Fig. 2C). Because there
was not a full recovery in body weight
after the first LPS injection in WT rats,
we calculated LPS-induced loss in body
weight by comparing the weight during
days 1–4 after injection to the weight at
the time of the most recent injection.
The second LPS injection induced a sig-
nificantly (p 	 0.05) less pronounced
reduction of body weight (3.4  0.5% after the second LPS
injection vs 7.1  0.7% after the first injection) and faster
recovery in WT rats (Fig. 2D), suggesting the development of
tolerance to its effects.
LPS induces a transient reduction in ethanol self-administration
in WT, but not Tlr4 KO rats
At the end of self-administration training, the baseline lever
presses for 10% ethanol were 19.8 6.6 for WT and 13.3 4.1
for KO rats. LPS (1 mg/kg, i.p.) was injected 30 min before the
next session and rats were tested for ethanol and water self-
administration in 30 min sessions for 14 consecutive days, fol-
lowed by a second LPS injection and 14more days of testing.Data
after both LPS injections were averaged. Amixed-factorial ANOVA
with genotype (Tlr4 KO vsWT) as the between-subjects factor and
time point (baseline, 1–4 d post-LPS, and 5–14 d post-LPS) as
the within-subjects factor showed a significant effect of time point
(F(1,8)  7.5; p 	 0.01) and genotype  time point interaction
(F(2,8) 5.6; p	 0.05). A Newman–Keuls post hoc test showed that
LPS treatment reduced operant responding for ethanol in the WT
group(p	0.05) for 4 consecutivedays after the injections (Fig. 3A).
No genotype differences were found 5–14 d after LPS injections. A
mixed-factorial ANOVA of the water self-administration data
showed a significant effect of time point (F(1,8) 7.5; p	 0.01), but
no difference in the genotype time point interaction (Fig. 3B).
Lack of evidence for a role of TLR4 in ethanol consumption
No genotype differences in ethanol self-administration by WT or
Tlr4 KO rats before or after dependence
Although there was no significant genotype effect on baseline re-
sponses in the ethanol self-administration test above, we compared
operant respondingbefore andafter ethanol dependence specifically
Figure 5. 2BC ethanol intake in male and female WT and Tlr4 KO rats. A, Ethanol (10%) intake (g/kg/24 h), (B) water intake
(ml/kg/24 h), (C) ethanol preference, and (D) bodyweight (g) inmale and femaleWT and Tlr4KO rats during 2BC drinking sessions
measured over 5weeks. The data are presented asmean SEM. Datawere analyzed using 2 2 5 (genotype by sexweek)
mixed ANOVAs (WTmale, n 23; WT female, n 16; KOmale, n 15; KO female, n 11). *Significant ( p	 0.05) difference
betweenmale and female ratswithingenotype; #significant ( p	0.05) differencebetweenweek1anda subsequentweek for the
respective sex within genotype.
Harris et al. • TLR4 and Alcohol Responses J. Neurosci., February 1, 2017 • 37(5):1139–1155 • 1145
in both genotypes. Figure 4A shows ethanol
self-administration inWT andTlr4KO rats
before ethanol vapor exposure (predepen-
dence).Operant self-administration of 10%
ethanol varied over time (session effect:
F(11,143) 3.3, p	 0.0005), but there were
no genotype or genotype  time differ-
ences. After CIE vapor exposure (after de-
pendence), there were also no differences in
self-administration, with bothWT andTlr4
KO rats showing similar increases in intake
(F(1,13) 12.3, p	 0.005; Fig. 4B).
2BC ethanol intake in male and female
WT vs Tlr4 KO rats
We then compared sexes and genotypes in a
2BC chronic drinking paradigm (WT: males,
n 23; females, n 16; Tlr4 KO: males, n
15; females, n  11). The omnibus mixed ANOVA of the ethanol-
drinking data revealed a marginally significant 3-way (genotype 
sex  week) interaction for 10% ethanol (v/v) intake (F(4,244)  2.4,
p  0.05). There was a significant two-way (sex  week) interaction
(F(4,244)  3.3, p  0.01) and a marginally significant main effect of
sex (F(1,61)  4.0, p  0.05). As seen in Figure 5A, female rats drank
more ethanol initially than male rats. This effect was observed for the
Tlr4 KO rats only during the first week of ethanol access (F(1,25) 
11.7, p 	 0.01), whereas the WT rats displayed this effect across the
first 3 weeks of ethanol access (F(1,38) 4.5, p	 0.05). There were also
changes in ethanol intake across weeks; specifically, WT male rats
displayed significant (p	 0.05) increases between week 1 versus week
4 and week 1 versus week 5, whereas Tlr4 KO male rats displayed
significant (p 	 0.05) increases between week 1 versus week 2 and
week 1 versus week 5. There was a significant decrease in ethanol
intake by female Tlr4 KO rats between weeks 1 and 2. The omnibus
mixed ANOVA of the water-drinking data revealed a significant two-
way (sex  week) interaction (F(4,244) 8.5, p 	 0.001) and a signif-
icant main effect of week (F(4,244)  6.7, p 	 0.001). As shown in
Figure 5B, male rats initially drank more water than females, with the
effect reaching significance (p 	 0.05) in the WT, but not Tlr4 KO,
rats during week 1. In addition, a modest but significant (p 	 0.05)
increase across weeks was observed in both the female Tlr4 KO (week
1 vs week 4 and week 1 vs week 5) and WT (week 1 vs week 3, week 1
vs week 4, and week 1 vs week 5) rats. The omnibus mixed ANOVA of
the ethanol preference data revealed a significant two-way (sex 
week) interaction (F(4,244)  12.6, p 	 0.001) and significant main
effects of week (F(4,244)  2.9, p 	 0.05) and sex (F(1,61)  22.4, p 	
0.001). However, the main effect of genotype regarding ethanol pref-
erence did not reach significance (p 0.06). Female WT and KO rats
displayed decreased ethanol preference across weeks 4–5 and 3–5,
respectively, compared with the first week (Fig. 5C). The omnibus mixed
ANOVAof thebodyweightdata revealeda significant two-way(sexweek)
interaction (F(4,244) 8.5, p	 0.001), along with significant main effects of
week (F(4,244) 6.7, p	 0.001) and sex (F(1,61) 505.5, p	 0.001). As seen
in Figure 5D, female rats weighed significantly less than male rats, with no
differences observed for genotype.
No significant effect of ()-naloxone on DID in C57BL/6J mice
We examined the effect of pharmacological inhibition of TLR4
signaling in mice using a binge-like drinking model. ()-
Naloxone treatment did not alter ethanol (20%) intake (Fig. 6A)
or BECmeasured on drinking day 4 of theDID test. There was no
overall effect of ()-naloxone at 2 h (F(2,21) 1.4, p 0.3) or 4 h
(F(2,21) 0.1, p 0.9), nor was there an effect on BECmeasured
at 4 h (F(2,21) 0.4, p 0.7). BECs for vehicle-treated, 30 mg/kg
()-naloxone-treated, and 60mg/kg ()-naloxone-treatedmice
were 73.6  13.7, 80.8  19.8, and 58.2  19.7 mg/dl, respec-
tively. Administration of 60 mg/kg ()-naloxone over 4 d also
had no significant effect onDID (Fig. 6B) or on BEC. There was a
trend toward reduction of drinking by ()-naloxone at 2 h
(F(1,14) 3.1, p 0.1), but not at 4 h (F(1,14) 1.5, p 0.2). BECs
measured at 4 h for vehicle- and 60 mg/kg ()-naloxone-treated
mice were 71.9 21.2 and 41.9 5.6mg/dl, respectively, but the
effect was not significant (F(1,14) 1.9, p 0.2).
Effect of ()-naloxone on 2BC and CIE-2BC drinking in
C57BL/6J mice
We then tested the effect of individual injections of ()-naloxone
(3–60 mg/kg) in mice under conditions of 2BC excessive drink-
ing after CIE exposure. BECs were 186.6  7.2, 149.6  10.7,
Figure 6. Effect of ()-naloxone on ethanol intake in the DID test in C57BL/6J mice. A, Male C57BL/6J mice were
injected with ()-naloxone (0, 30, or 60 mg/kg; n 8 per group) 30 min before the start of the drinking session (20%
ethanol) on day 4 of the DID protocol and intake was measured after 2 or 4 h. B, Male mice were injected with saline
(vehicle) or 60 mg/kg ()-naloxone 30min before the start of the DID (20% ethanol) session for 4 d (n 8 per group). The
data are presented as mean SEM. Data were analyzed separately at the 2 and 4 h time points using one-way ANOVA with
()-naloxone dose as the between-subjects factor.
Figure 7. Effect of ()-naloxone on ethanol intake in the 2BC and CIE-2BC tests in
C57BL/6J mice. A, Effect of individual doses of ()-naloxone on 2BC intake (g/kg/2 h).
Increased ethanol (15%) consumption was observed in the CIE-2BC group compared with
the control 2BC group (t(28) 5.8, p	 0.0001). Male C57BL/6J mice (n 15 per group)
were administered ()-naloxone (0, 3, 10, 30, 60 mg/kg) in a within-subject manner
(every 3– 4 d) 30 min before 2BC testing. The data are presented as mean SEM. Data
were analyzed by two-way repeated-measures ANOVA (group as the between factor; dose
as the within factor). B, Effect of 4 d of 60mg/kg ()-naloxone treatment on 2BC drinking
(g/kg/2 h). Themicewerethendividedintotwogroupstoreceive()-naloxoneorvehiclebasedon
equal drinking averages. Male mice in a between-subject design (n 4–6 per group: control-
vehicle, control-60mg/kg()-naloxone,CIE-vehicle,CIE-60mg/kg()-naloxone)were injected30
min before 2BC testing across 4 d. The data are presented as mean SEM. Data were analyzed by
three-way repeated-measures ANOVA (group and dose as the between factors; day as the within
factor). **p	 0.01 comparedwith baseline.
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174.8 9.8, and 176.6 9.0mg/dl across the four cycles of vapor
exposure. Increased ethanol (15%) drinking over 2 h was ob-
served in the CIE-2BC group compared with the control 2BC
group (Fig. 7A). An overall within-subjects ANOVA revealed a
significant effect of group (F(1,28)  30.5, p 	 0.0001) and a
group dose interaction (F(4,112) 3.2, p	 0.05). Further anal-
ysis revealed that this interaction was due to the decrease in eth-
anol intake by 60 mg/kg ()-naloxone compared with vehicle
(p 	 0.01) and compared with 3 mg/kg (p 	 0.05), 10 mg/kg
(p 	 0.01), and 30 mg/kg (p 	 0.01) ()-naloxone in the CIE
group. There was no effect of ()-naloxone in the control
2BC group. To further explore the high dose, we treated separate
groups of control 2BC and CIE-2BC mice with 60 mg/kg ()-
naloxone for 4 d (Fig. 7B). There was a significant difference
between 2BC and CIE-2BC mice in baseline drinking (F(1,16) 
23.2, p 	 0.001) after vapor exposure. These groups were each
Figure 8. Effect of Tlr4 knockdown in NAc on ethanol intake in the continuous and intermittent access 2BC tests in Tlr4 F/F malemice. A–C, Ethanol intake (g/kg/24 h) (A), preference for ethanol
(B), and total fluid intake (g/kg/24 h) (C) in the 2BC continuous access test in untreated control Tlr4 F/Fmice (n 10) and Tlr4 F/Fmice injectedwith LV-Cre-EGFP (n 20) or LV-Cre-Empty (n 10).
D–F, Ethanol (15%) intake (g/kg/24 h) (D), preference for ethanol (E), and total fluid intake (g/kg/24 h) (F ) in the 2BC intermittent access test in untreated control Tlr4 F/Fmice (n 10) and Tlr4 F/F
mice injected with LV-Cre-EGFP (n 20) or LV-Cre-Empty (n 11). Each point is the average of 2 d of drinking. The data are presented as mean SEM. Data were analyzed by two-way
repeated-measures ANOVA.
Figure 9. Verification of injection site after Tlr4mRNA knockdown in NAc. A, Composite microscope image of a coronal section of the NAc after lentivirus injection using fluorescent microscopy
(left) to show EGFPmarker signal (green) and bright-field (right) to demonstrate neuroanatomy.B, Coronal brain atlas diagramof the NAc injection sitewith blue circles showing the NAc and green
ovals illustrating the typical lentivirus location and spread.
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divided into two subgroups to receive ()-naloxone or vehicle
based on equal drinking averages and equal BECs in the CIE-2BC
groups. Vapor chamber BECs for the vehicle-treated mice were
165.7 12.5, 176.6 3.2, 176.6 16.8, and 214.9 20.0 mg/dl
and BECs for the 60 mg/kg ()-naloxone-treated mice were
170.7 14.1, 187.9 9.6, 191.3 9.1, and 214.1 14.4 mg/dl
across the 4 cycles of exposure. Although the CIE effect was sig-
nificant (F(1,16) 30.2, p	 0.001), there was no significant treat-
ment effect (F(1,16)  0.0005, p  1.0) or group  treatment
interaction (F(1,16)  0.2, p  0.6). Within-dose comparisons
across injections also revealed no overall significant effects, but if
each treatment day is compared with baseline, there was a signif-
icant effect of 60mg/kg ()-naloxone on day 3 (p 0.03). How-
ever, drinking did not differ from vehicle-treatedmice on this (or
any other) day. These results support a modest but inconsistent
effect of 60 mg/kg ()-naloxone on ethanol drinking in depen-
dent mice.
Effect of Tlr4 mRNA knockdown in mouse NAc on 2BC drinking
Selective knockdown of TLR4 signaling in the CeA or VTA (but
not the VP) decreased binge-like drinking in P rats (Liu et al.,
2011; June et al., 2015). In the current study, we examined Tlr4
knockdown in mouse NAc, another important brain region in
binge drinking. However, knockdown in the NAc did not alter
ethanol intake, preference for ethanol, or total fluid intake in the
24 h continuous access 2BC test in which Tlr4F/F treated and
untreated mice could drink either water or a series of increasing
ethanol (3–16%) concentrations (Fig. 8A–C).
In the 2BC test with intermittent access to 15% ethanol, com-
parison ofTlr4F/F treated (LV-EGFP-Cre; LV-EGFP-Empty) and
control (untreated) mice revealed a significant treatment  day
interaction for ethanol consumption (F(6,174) 2.3; p	 0.05), but
not for ethanol preference or total fluid intake (Fig. 8D–F). Two-
way repeated-measures ANOVA showed no main effect of treat-
ment in any test.Post hoc analyses for each daywhen corrected for
multiple comparisons also showed no significant differences be-
tween LV-EGFP-Cre versus LV-EGFP-Empty treatedmice or be-
tween LV-EGFP-Cre treated versus control untreated mice.
Although there was a trend toward increased alcohol consump-
tion in the intermittent test afterTlr4mRNAknockdown inNAc,
this was not statistically significant.
Verification of Tlr4 knockdown in NAc
Verification of successful knockdown of Tlr4mRNA in the NAc
involved a two-step process: (1) confirmation of needle place-
ment and (2) quantitation of Tlr4 mRNA. Half of the treated
(LV-EGFP-Cre, LV-EGFP-Empty)Tlr4F/Fmicewere used to ver-
ify injection coordinates. Figure 9A is a representative image of a
coronal section of the NAc (AP 1.49 mm) from a lentivirus-
treated Tlr4F/F mouse. The left side is a fluorescent image that
shows the EGFP signal (surrogatemarker for lentivirus transduc-
tion) in green and DAPI (a stain that visualizes the nuclei of all
cells) in blue. The right side of the image is a bright-field image
used to better visualize the neuroanatomical landmarks. Figure
9B is a brain atlas image of a coronal section (AP 1.49 mm)
showing the desired target coordinates, with the blue circles high-
lighting the NAc and the green ovals demonstrating the location
of the LV-EGFP-Cre and LV-EGFP-Empty infection. All samples
obtained frommice in both drinking experiments were on target
and demonstrated an EGFP signal that covered at least one-third
of the NAc.
Micropunches of the injection site were obtained from the
other half of the treated (LV-EGFP-Cre, LV-EGFP-Empty)
Tlr4F/F mice. The extracted RNA had excellent yields, purity, and
quality; RNA integrity numbers averaged 8.0, indicating little
or no degradation, and the 260/230 and 260/280 ratios were
2.0. We observed 60% knockdown (p 	 0.001) of Tlr4
mRNA relative to the endogenous control 8 weeks after injection
in mice exposed to 2BC continuous and intermittent access
drinking tests (Fig. 10).
Role of TLR4 in the acute behavioral actions of ethanol
Reduced duration of ethanol-induced LORR in Tlr4 KO rats
Previous work inmice showed that lack ofTlr4 or administration
of ()-naloxone reduced the duration of LORR induced by a
single high dose of ethanol (4.5 g/kg) (Corrigan et al., 2015). We
tested a single high dose of ethanol (4.0 g/kg) in rats and also
found that the latency to induction of ethanol-induced LORR
was significantly increased (Fig. 11A) and the duration of LORR
was significantly reduced (Fig. 11B) in Tlr4 KO rats compared
with WT rats.
Role of TLR4 in GABAergic transmission in CeA neurons
Spontaneous GABAergic transmission
We examined GABAergic transmission in CeA neurons from
Tlr4 KO and WT rats based on the evidence for TLR4 pathway
signaling in GABAergic synapses in mouse CeA (Bajo et al.,
2014). The effect of an acute application of ethanol (44 mM) on
GABAergic transmission was tested in CeA neurons of naiveWT
and Tlr4 KO rats and after CIE or a single LPS challenge (exper-
iments performed 7–10 d after LPS injection). We found no sig-
nificant differences in the baseline s/mIPSC frequencies,
amplitudes, or decay times in CeA neurons from WT and Tlr4
KO mice (Table 1). However, we observed a significant (p 	
0.05) difference in baseline mIPSC rise times between the geno-
types (Table 1). In addition, whereas LPS andCIE treatments had
no effect on s/mIPSC parameters across genotypes, both treat-
ments significantly (p	 0.05) altered s/mIPSC rise times in WT
and Tlr4 KO mice (Table 1).
Acute ethanol application
We also compared the effects of acute ethanol application on
GABAergic transmission in CeA neurons from naive WT and
Figure 10. Verification of Tlr4 mRNA knockdown after lentivirus injections in NAc. Tlr4
mRNA levels in the NAc target site were assessed by qPCR and normalized relative to Gadph
mRNA levels after the 2BC continuous access (n 12, LV-EGFP-Cre; n 7, LV-EGFP-Empty)
and 2BC intermittent access tests (n  11, LV-EGFP-Cre; n  7, LV-EGFP-Empty). Values
(mean SEM) are shown relative to LV-EGFP-Empty treatedmice; ***p	 0.001 determined
by Student’s t test.
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Tlr4 KO rats. Ethanol (44 mM) significantly (p 	 0.01–0.05)
increased s/mIPSC frequencies in CeA neurons from both geno-
types; ethanol increased the mean sIPSC frequency by 37.6 
11.4% inWT and 45.7 14.2% in Tlr4KO rats (Fig. 12A,B) and
increased themIPSC frequency by 26.4 7.1% inWTand 43.6
13.5% in Tlr4 KO rats (Fig. 13C,D). Acute ethanol did not alter
s/mIPSC amplitudes or kinetics in CeA neurons from either ge-
notype (Fig. 12). There was no significant difference in the acute
ethanol-induced increases of CeAGABA release in neurons from
naive WT and Tlr4 KO rats.
CIE vapor exposure
In CeA neurons from CIE-treated WT and Tlr4 KO rats, acute
ethanol (44 mM) application also increased s/mIPSC frequencies
(Fig. 13). Two-way repeated-measures ANOVA of the peak eth-
anol effects from all of the tested cells showed a significant main
effect of ethanol (F(1,16) 9.3, p	 0.05), but no effect of genotype
or interaction between ethanol and genotype. Ethanol signifi-
cantly facilitated sIPSC frequencies in WT neurons by 57.2 
4.3%, but had mixed effects in the CeA neurons from Tlr4 KO
rats. For example, ethanol enhanced sIPSC frequencies in only 6
of 10 Tlr4 KO neurons (47% of control) and either decreased (	
85% of control, n 3) or had no effect (85–115% of control, n
1) in the remaining neurons. Although the magnitude of the
acute ethanol effect on s/mIPSC frequencies was similar in CIE-
treated and naive WT and Tlr4 KO rats, the ethanol-induced
facilitation of sIPSC frequency was transient (5–6 min) in the
CIE-treated Tlr4 KO rats compared with the other 3 groups
(12–15 min; data not shown). Consistent, sustained ethanol-
induced increases in mIPSC frequencies were observed in both
WT andTlr4KOneurons. Two-way repeated-measures ANOVA
showed a significant main effect of ethanol (F(1,9)  19.8, p 	
0.05), but not genotype or the interaction
between ethanol and genotype. There
were no significant acute ethanol-induced




We investigated the effects of acute etha-
nol application on CeA neurons fromWT
and Tlr4 KO rats 7–10 d after a single LPS
injection (1 mg/kg, i.p.). There was a sig-
nificant main effect of ethanol treatment
(F(1,13) 5.9, p	 0.05), but not genotype,
and no significant interaction between ge-
notype and ethanol. Ethanol (44 mM) had
opposite effects on sIPSC frequency in WT versus Tlr4 KO rats,
represented by a significant reduction of 41.4  4.0% in the
LPS-treatedWT neurons (Fig. 14). Although there was an overall
significant increase of 29.9 21.6% in sIPSC frequency by acute
ethanol in neurons from LPS-treated Tlr4 KO rats (Fig. 14), eth-
anol produced mixed, cell-specific effects; ethanol increased the
frequencies in 3 of 7 cells ( 115% of control, n 3), but had no
effect (85–115% of control, n  4) in the others. There were no
significant ethanol-induced changes in the sIPSC amplitude and
kinetics between the two groups.
Finally, we compared the normalized effects of acute ethanol
on s/mIPSC frequencies across the different treatment groups
using two-way ANOVA. There was a significant main effect of
treatment (F(2,46)  6.7, p 	 0.01), but not genotype (F(2,46) 
1.3, p 0.05), on sIPSC frequencies and a significant interaction
between treatment and genotype (F(2,46)  7.3, p 	 0.01). Bon-
ferroni post hoc tests showed significant differences in ethanol
effects in the LPS-treated rats compared with naive and CIE-
treated WT rats, whereas there were no significant differences
among the individual treatment groups of Tlr4 KO rats. There
were no main effects of treatment or genotype on acute ethanol-
induced potentiation of mIPSC frequencies between naive and
CIE-treated rats.
Discussion
INIA-Neuroimmune investigators used extensive behavioral and
electrophysiological tests to examine the role of TLR4 in acute
and chronic ethanol responses in rats and mice (summarized
in Table 2). Different genetic and pharmacologic approaches
were used to inhibit TLR4-mediated signaling and different
Figure 11. The sedative effects of ethanol are reduced in Tlr4 KOmale rats. Left panel, Time to LORR inmaleWT and Tlr4 KO rats
(n 10 per group, df 18, t 2.3, p	 0.05). Right panel, Time of LORR inWT and Tlr4 KO rats (n 10 per group, df 18, t
3.9, p	 0.01). The data are presented asmean SEM inminutes. *p	 0.05 and **p	 0.01 determined by unpaired Student’s
t test.
Table 1. Baseline spontaneous andminiature IPSCs in CeA neurons from naive, CIE-treated, and LPS-treatedWT and Tlr4 KO rats
Group
Spontaneous IPSCs Miniature IPSCs
Frequency Amplitude Rise time** Decay time Frequency Amplitude Rise time*## Decay time
WT Naive 1.1 0.4 79.6 6.1 2.8 0.1 8.7 0.9 0.5 0.1 52.7 2.2 3.1 0.2 7.1 1.9
KO Naive 1.1 0.4 78.9 11.3 3.1 0.2 9.1 0.9 0.3 0.1 56.8 3.7 2.5 0.1 5.6 0.4
WT CIE 1.0 0.4 65.2 6.1 2.7 0.1 8.5 0.7 0.3 0.1 46.6 6.7 2.7 0.2 5.6 0.8
KO CIE 1.0 0.4 80.2 13.6 2.4 0.2 8.7 1.1 0.4 0.1 58.8 5.4 2.2 0.1 6.1 0.5
WT LPS 1.3 0.3 98.9 19.1 2.5 0.1 10.6 0.8 N/A N/A N/A N/A
KO LPS 1.5 0.6 70.7 5.7 2.4 0.1 8.6 1.7 N/A N/A N/A N/A
IPSCs in CeA neurons from naive rats (WT: n 13; KO: n 12), CIE-exposed rats (WT: n 8; KO: n 10), and ethanol-naive rats (WT: n 8; KO: n 8) injected with LPS (1 mg/kg, i.p.). Two-way ANOVA revealed no main effects of
treatment, genotype, or the interaction of baseline frequencies, amplitudes, and decay times of the spontaneous IPSCs. There was a main effect of treatment (F(2,53) 7.7; p	 0.01) on the rise time, but no main effect of genotype or
interaction between genotype and treatment. Likewise, there were nomain effects of treatment or genotype and no interaction between treatment and genotype on the frequency, amplitude, and decay time of baseline miniature IPSCs
from naive (WT: n 5; KO: n 9) and CIE-exposed (WT: n 5; KO: n 6) rats. However, there were significantmain effects of treatment (F(1,21) 7.4, p	 0.05) and genotype (F(1,21) 13.8, p	 0.01) on baselineminiature IPSC rise
time, but no interaction between genotype and treatment. Values are mean SEM.
*p	 0.05, **p	 0.01, effect of treatment; ##p	 0.01, effect of genotype.
N/A, Not applicable.
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models of voluntary ethanol intake were studied in male and
female rodents.
In addition to genotyping, rats were injected with LPS to verify
that TLR4, a primary target, was nonfunctional in the KO animals.
LPS produced “sickness-like” behavior in naive and ethanol-treated
WT rats, represented by decreased food/water intake and body
weight; however, Tlr4 KO rats were resistant to these effects as re-
ported previously in Tlr4KOmice (Qureshi et al., 1999; Kalis et al.,
2003; von Meyenburg et al., 2004; Yang et al., 2014). We further
demonstrated that WT ethanol-trained rats developed tolerance to
LPS-induced toxicity in agreementwith studies in ethanol-naive rats
(McCarthy et al., 1984; Cross-Mellor et al., 2000). Female B6 mice
also showed evidence of tolerance to decreased body weight after a
second LPS injection (Blednov et al., 2011).
LPS increased ethanol consumption in mice (Blednov et al.,
2011) and elevated serum levels of LPS were positively correlated
with alcohol craving in humans (Leclercq et al., 2012; Leclercq et al.,
2014). InWT rats, LPS transiently reduced ethanol self-administra-
tion, but had no long-term effects on drinking in either genotype.
The initial reduction inethanol responding (1–4dafterLPS)maybe
due to induction of “sickness-like” behavior that affects themotiva-
tion for ethanol similar to effects on food/water intake.We foundno
differences in ethanol self-administration in WT and Tlr4 KO rats
beforeorafterdependenceandnoconsistent genotypedifferences in
2BC drinking over 5 weeks. The inconsistent decrease in depen-
dence-driven drinking by 60 mg/kg ()-naloxone may be due to
nonspecific/aversive effects of this high dose, as reported in rats
(Tanda et al., 2016).
TLR4 knockdown in the CeA or VTA decreased binge drink-
ing in P rats (Liu et al., 2011; June et al., 2015). Given the prom-
inent role of the NAc within the mesocorticolimbic reward
circuit in alcohol abuse and dependence, we further studied the
effects of TLR4 in this brain region.However,Tlr4mRNAknock-
down in mouse NAc did not reduce 2BC continuous or limited
access drinking. In addition to brain region, there are other key
differences between the studies. We examined male C57BL/6J
mice using the 2BC continuous and intermittent models,
whereas the previous work was in P rats (the sex was not re-
ported) using a binge-drinking model. The P rats had increased
levels of GABAA receptor 2 subunits and TLR4 in the CeA and
VTA, and 2 subunit-specific knockdown in the CeA inhibited
TLR4 function and decreased drinking (Liu et al., 2011). Further-
more, Tlr4 knockdown in the CeA decreased 2 subunit expres-
sion and also reduced drinking (Liu et al., 2011). Therefore, the
TLR4-related effects on binge drinking in P rats may be due to
altered GABAergic (2 subunit-specific) responses.
Although TLR4 signaling did not regulate ethanol consump-
tion consistently in our rodent models or in other studies
Figure 12. Acute ethanol potentiates spontaneous andminiature GABA release in CeA neu-
rons fromethanol-naiveWTand Tlr4KO rats.A, Traces of representative sIPSC recordings of CeA
neurons from naive WT (left) and Tlr4 KO (right) male rats before and after acute bath applica-
tion of ethanol (44mM).B, Acute ethanol increased themean sIPSC frequency in CeAneurons by
37.6 11.4% inWT (from1.4 0.5 to 1.6 0.6Hz, n 9) and by 45.7 14.2% in KO (from
0.9  0.2 to 1.2  0.3 Hz, n  10) rats. There was a significant main effect of ethanol
(F(1,17)) 11.0, p	 0.01), but no main effect of genotype or interaction between ethanol
4
andgenotype. Acute ethanol did not have significant effects on sIPSC amplitudes (WT: 111.3
9.4%of control; KO: 115.85.1%of control) or kinetics (rise time:WT, 97.03.3%of control;
KO, 106.6 3.7% of control; decay time: WT, 112.5 7.5% of control; KO, 117.6 9.7 of
control). C, Representative mIPSCs recorded from CeA neurons of naive WT and Tlr4 KO rats
showing an increase in mIPSC frequencies after acute ethanol application. D, Acute ethanol
increasedmIPSC frequencies in CeAWTand Tlr4KOneurons. Therewas a significantmain effect
of ethanol (F(1,12)11.8,p	0.05) onmIPSC frequencies inWT (26.47.1%; from0.50.1
to 0.6 0.1 Hz, n 5) and KO neurons (43.6 13.5%; from 0.3 0.1 to 0.4 0.1 Hz, n
9), but no significant main effects of genotype or the interaction between ethanol and geno-
type. Ethanol had no effects on mIPSC amplitudes (WT: 100.3 2.0% of control; KO: 93.6
3.6%of control) or kinetics (rise time:WT, 90.9 2.8%of control; KO, 99.9 4.9%of control;
decay time:WT, 102.92.3%of control; KO, 96.711.6%of control) inneurons fromWTand
Tlr4 KO rats. Statistical significance was calculated by two-way repeated-measures ANOVA
(#p	 0.05). The data are presented as mean SEM.
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(Alfonso-Loeches et al., 2010; Pascual et al., 2011; Bajo et al.,
2016; Blednov et al., 2017a), Tlr4 KO rats displayed lower sensi-
tivity than WT to the acute sedative effects of ethanol. This is
consistent with results in mice lacking Tlr4 or WT mice treated
with ()-naloxone (Wu et al., 2012b; Corrigan et al., 2015; Bled-
Figure 13. Acute ethanol enhances GABA release in CeA neurons fromWT and Tlr4 KO rats
differentially after CIE exposure. A, Traces of sIPSC recordings in CeA neurons fromWT and Tlr4
KO male rats exposed to CIE vapor. B, Bath application of 44 mM ethanol facilitated sIPSC
frequencies inWT neurons significantly by 57.2 4.3% (from 1.0 0.4 to 1.5 0.6 Hz, n
8), but enhanced frequencies in only 6 of 10 KO neurons (46.5 23.1% of control; from 1.2
0.7 to 1.7  0.8 Hz, n  6) and decreased (	 85% of control, n  3) or had no effect
(85–115% of control, n 1) on sIPSC frequencies in the remainder (85.5 9.3% of control;
4
from 0.7 0.1 to 0.5 0.04 Hz) of KO neurons. Two-way repeated-measures ANOVA of the
peak ethanol effects from all of the tested cells showed a significant main effect of ethanol
(F(1,16) 9.3, p	 0.05), but no effect of genotype or interaction between ethanol and geno-
type. The acute ethanol effects on sIPSC frequencies were transient in the neurons from KO
compared with WT rats. C, Representative mIPSCs in CeA neurons from WT and Tlr4 KO rats
chronically exposed to ethanol.D, Acute ethanol (44mM) application increasedmIPSC frequen-
cies in WT and Tlr4 KO neurons by 55.1 19.9% (from 0.3 0.1 to 0.4 0.1 Hz, n 5) and
58.6 22.6% (from 0.4 0.1 to 0.5 0.8 Hz, n 6), respectively. Two-way repeated-
measures ANOVA showed a significantmain effect of ethanol (F(1,9) 19.8, p	 0.05), but not
genotype or the interaction between ethanol and genotype. Acute ethanol had no significant
effects on the mean mIPSC amplitudes (WT: 104.8 6.9% of control; KO: 109.9 11.3% of
control) or kinetics (rise time:WT, 105.4 5.8%of control; KO, 112.0 6.2%of control; decay
time: WT, 115.1 13.3% of control; KO, 101.4 4.3% of control) in WT and Tlr4 KO rats. The
data are presented as mean SEM (#p	 0.05).
Figure14. LPS injection alters GABA responses to acute ethanol in CeAneurons fromWTbut
not Tlr4 KO rats. A, Representative recordings of sIPSCs from LPS-treated WT and Tlr4 KO male
rats.B, Seven to 10dafter a single LPS injection (1mg/kg, i.p.), acute 44mMethanol application
reduced sIPSC frequencies by 41.4 4.0% (from 1.3 0.3 to 0.7 0.2 Hz, n 8) in CeA
neurons from LPS-treatedWT rats. Ethanol’s effects on sIPSC frequencies in LPS-treated KO rats
(an overall increase of 29.9 21.6%, n 7) were more varied, with ethanol-induced poten-
tiation ( 115% of control, n 3) or no effect (85–115% of control, n 4) occurring in a
cell-specific manner. There was a significant main effect of ethanol treatment (F(1,13) 5.9,
p	0.05), but not genotype, andno interaction betweengenotype and ethanol. Therewere no
significant effects of acute ethanol on the amplitudes (WT: 93.6 12.9%; KO: 112.3 11.1%
of control) or kinetics (rise time:WT, 109.9 4.4%; KO, 97.8 2.2%; decay time:WT, 90.2
14.7%; KO, 115.2 10.1% of control) in LPS-treated WT and Tlr4 KO rats. The data are pre-
sented asmean SEM. Statistical significancewas calculated by two-way repeated-measures
ANOVA (#p	 0.05).
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nov et al., 2017b). A complex interaction between TLR2 and
TLR4 in ethanol-induced LORR was reported (Corrigan et al.,
2015) and ethanol also promoted physical TLR2/TLR4 interac-
tions in lipid rafts, which may facilitate immune activation
(Fernandez-Lizarbe et al., 2013). Therefore, a role for TLR signal-
ing in ethanol-induced sedation is emerging across species and
TLRs and associated pathways may regulate some of ethanol’s
acute responses synergistically.
We examined GABAergic transmission in CeA neurons be-
cause TLR4 pathway components were involved in ethanol’s
acute effects on GABAergic IPSPs in these synapses (Bajo et al.,
2014) and because Tlr4 knockdown in the CeA of P rats poten-
tially reduced drinking via a GABAergic mechanism (Liu et al.,
2011).Deletion ofTlr4did not affect baseline spontaneousGABA
release in CeA neurons, but altered the kinetics of GABAA
receptor-mediated IPSCs, indicating a role for TLR4 in GABAA
receptor function (Otis et al., 1994). Generally, the kinetic prop-
erties of GABAA-mediated currents are determined by subunit
composition, posttranslationalmodifications, trafficking, synap-
tic localization, and clustering (Jacob et al., 2008;Wuet al., 2012a;
Dixon et al., 2014) andwe cannot exclude potential contributions
from these factors.
Deletion of CD14, an accessory protein for LPS-mediated ac-
tivation of TLR4, had no effects on CeAGABAergic transmission
(Bajo et al., 2014), indicating different synaptic effects for differ-
ent TLR4 pathway components. However, frequencies of sIPSCs
and tonic currents were altered in Il1rn KO mice (Bajo et al.,
2015). Collectively, our findings support distinct roles for neuro-
immune regulators in basal GABAergic transmission.
Acute ethanol increased action potential-dependent and
-independent GABA release in CeA neurons fromnaive andCIE-
treated WT and Tlr4 KO rats in agreement with previous studies
(Roberto et al., 2003; Roberto et al., 2004; Gilpin et al., 2011; Cruz
et al., 2013; Herman et al., 2013). The lack of differences in acute
ethanol effects on spontaneous GABAergic transmission, espe-
cially in naive rats, agrees with our study suggesting that CD14
(rather than TLR4) is critical for ethanol effects in CeA neurons
(Bajo et al., 2014). After LPS exposure, acute ethanol reduced
CeA GABAergic transmission in WT but not Tlr4 KO neurons.
Previous work in mice showed that LPS reduced firing of VTA
neurons and increased ethanol drinking (Blednov et al., 2011).
Despite the synaptic changes in WT neurons observed 7–10 d
after LPS exposure, LPS did not alter ethanol self-administration
in WT or Tlr4 KO rats at this time point. Although our results
support the involvement of the TLR4 pathway in regulating CeA
GABA transmission, it is likely that other immune mediators
released during LPS-induced peripheral and central immune ac-
tivation contribute to the altered ethanol effects in WT synapses.
In Tlr4 KO rats after CIE or LPS treatment, we observed cell-
specific responses to acute ethanol similar to the variable ethanol
effects in naive Cd14 or Il1rn KO mice (Bajo et al., 2014; Bajo et
al., 2015). Activation of peripheral immune responses is known
to stimulate discrete CeA neurons (Day et al., 1999; Serrats et al.,
2006). Overall, these findings point to distinct neuronal popula-
tions and circuits in the CeA whose basal activities or ethanol
responses are regulated differentially by proinflammatory/neu-
roimmune molecules.
We used differentmethods to target TLR4 and differentmod-
els of ethanol intake, but there was little evidence that TLR4 reg-
ulates drinking directly. In microglia, ()-naloxone and ()-
naltrexone may block TLR4 downstream signaling preferentially
via the TRIF-IRF3 pathway (Wang et al., 2016), indicating that
they may not block all arms of TLR4 signaling. Given that there
were no consistent differences in 2BC drinking and operant self-
administration of ethanol between WT and Tlr4 KO rats, it is
unlikely that the lack of (DID and 2BC) or inconsistent (CIE-
2BC) effect of ()-naloxone is due to incomplete TLR4 inhibi-
tion, particularly at the 60mg/kg dose. Collectively, our results in
mice and rats are in agreement with studies showing thatTlr4KO
and WT mice did not differ in ethanol consumption (Alfonso-
Loeches et al., 2010; Pascual et al., 2011; Blednov et al., 2017a).
Our ()-naloxone results in mice are consistent with another
TLR4 inhibitor that also decreased ethanol consumptionnonspe-
cifically in mice (Bajo et al., 2016). To date, only knockdown of
Tlr4mRNA in the CeA or VTA of P rats decreased binge drinking
and this was associated with 2 subunit-specific GABAergic sig-
naling. However, there is now consistent evidence across species
for a role of TLR4 in mediating the acute sedative effects of alco-
hol, which could be an indicator of overall sensitivity to alcohol
and susceptibility to develop dependence.
TLR4 mediates ethanol-induced increases in brain cytokines/
chemokines and neurodegeneration and inhibition of TLR4 pre-
vents or reverses ethanol-induced neuroimmune responses
(Fernandez-Lizarbe et al., 2009; Alfonso-Loeches et al., 2010; Zou
Table 2. Summary of tests performed in rats andmice
Behavioral and electrophysiological tests in rats
Groups Body weight Operant (30 min) 2BC (24 h) LORR Acute ethanol s/mIPSCs
Frequency Amplitude/kinetics
WT vs Tlr4 KO (naive) — (10%) (10%)a 1 — —
WT vs Tlr4 KO (CIE-treated) (10%) — —
WT vs Tlr4 KO (LPS-treated) 2 21–4 d (10%) 2 —
Drinking tests in mice
Groups 2BC (24 h) 2BC, CIE-2BC DID (2,4 h)
Control vs LV-EGFP-Cre Tlr4F/F (3–16%)
(15%, intermittent)
Control vs ()-naloxone (3–60 mg/kg) (15%)b (20%)b
Control vs ()-naloxone (60 mg/kg, 4 d) (15%)b (20%)b
Overall changes inWT/control groups comparedwith Tlr4mutants or the TLR4antagonist ()-naloxone in ethanol drinking tests (ethanol concentrations are in parentheses) in rats andmice, ethanol (4 g/kg)-induced LORR in rats, andacute
ethanol (44 mM)-induced s/mIPSCs in rat CeA neurons.
–, No significant difference between groups (control vs Tlr4mutants or control vs TLR4 antagonist treatment);1 and2, increased and decreased responses in WT vs KO rats, respectively.
aNo consistent genotype differences across weeks.
bDecreased ethanol consumption in 2BC-CIE mice at 60 mg/kg, but not consistently across studies (i.e., day 1 in within-subject study, but only day 3 in repeated treatment study).
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and Crews, 2014; Bajo et al., 2016). Chronic ethanol exposure
may also disrupt the integrity of the blood–brain barrier via
TLR4-dependent signaling (Rubio-Araiz et al., 2016). TLR4 was
associated with cognitive impairment and anxiety-related behav-
ior during ethanol withdrawal (Pascual et al., 2011; Pascual et al.,
2015) and with synaptic remodeling and anxiety induced by
binge drinking in adolescent mice (Montesinos et al., 2016).
However, our comprehensive study using different species and
sexes, different methods to inhibit TLR4, and different tests of
chronic, dependence-driven, and binge-like consumption indi-
cates thatTlr4 is not a critical gene for regulating ethanol drinking
and inhibition of TLR4 signaling alone would not be an effective
therapeutic strategy. Ethanol promotes physical interactions
between TLR4 and TLR2 (Fernandez-Lizarbe et al., 2013) and
TLR4/TLR2 interactions were implicated in ethanol-induced se-
dation (Corrigan et al., 2015), which warrants consideration that
TLR4 and other neuroimmune mediators may regulate ethanol
responses synergistically. Analyses of the conserved cross-species
gene networks in alcoholics and animal models exposed to
chronic alcohol will help to prioritize immune/inflammatory
pathways (and candidate drugs) with improved therapeutic po-
tential for alcohol use disorders.
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